An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer

A simple molecular classification for endometrioid endometrial cancers that can be easily combined with Lynch syndrome screening provides important prognostic information. These findings support prospective clinical validation and further studies on the predictive value of a simplified molecular classification system.